Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Children's Hospital of Philadelphia
Philadelphia, United States
Sapienza University of Rome
Rome, Italy
University of Freiburg
Freiburg im Breisgau, Germany
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Brescia, Italy
University of Naples Federico II
Naples, Italy
Post Graduate Institute of Medical Education and Research
Chandigarh, India
Icahn School of Medicine at Mount Sinai
New York, United States
Medizinische Hochschule Hannover
Hanover, Germany
Hôpital Necker-Enfants Malades
Paris, France
Karolinska University Hospital
Stockholm, Sweden
References
References (76)
- 1
[X-linked agammaglobulinemia: experience in a Portuguese hospital].
Fernandes A, Guedes M, Vasconcelos J, et al.
Anales de pediatria (Barcelona, Spain : 2003) 2015; (82(3)):166-71.
PMID: 25443324 - 2
Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy.
Bearden D, Collett M, Quan PL, et al.
The journal of allergy and clinical immunology. In practice 2016; (4(6)):1059-1065 doi:10.1016/j.jaip.2015.12.015.
PMID: 26883540 - 3
X-linked Agammaglobulinemia.
Suri D, Rawat A, Singh S
Indian journal of pediatrics 2016; (83(4)):331-7 doi:10.1007/s12098-015-2024-8.
PMID: 26909497 - 4
Intravenous and subcutaneous immunoglobulin G replacement therapy.
Bonilla FA
Allergy and asthma proceedings 2016; (37(6)):426-431 doi:10.2500/aap.2016.37.3987.
PMID: 27931296 - 5
Gastrointestinal Manifestations in X-linked Agammaglobulinemia.
Barmettler S, Otani IM, Minhas J, et al.
Journal of clinical immunology 2017; (37(3)):287-294 doi:10.1007/s10875-017-0374-x.
PMID: 28236219 - 6
Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.
Pac M, Bernatowska EA, Kierkuś J, et al.
Archives of medical science : AMS 2017; (13(2)):412-417 doi:10.5114/aoms.2016.60338.
PMID: 28261296 - 7
Common Variable Immunodeficiency and Liver Involvement.
Song J, Lleo A, Yang GX, et al.
Clinical reviews in allergy & immunology 2018; (55(3)):340-351 doi:10.1007/s12016-017-8638-z.
PMID: 28785926 - 8
Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.
Pecoraro A, Crescenzi L, Granata F, et al.
International immunopharmacology 2017; (52()):136-142 doi:10.1016/j.intimp.2017.09.005.
PMID: 28898770 - 9
Autosomal Recessive Agammaglobulinemia - first case with a novel TCF3 mutation from Pakistan.
Qureshi S, Sheikh MDA, Qamar FN
Clinical immunology (Orlando, Fla.) 2019; (198()):100-101 doi:10.1016/j.clim.2018.07.016.
PMID: 30063982 - 10
The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.
Baumann U, Routes JM, Soler-Palacín P, Jolles S
Frontiers in immunology 2018; (9()):1837 doi:10.3389/fimmu.2018.01837.
PMID: 30147696 - 11
Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.
Schütz K, Alecsandru D, Grimbacher B, et al.
Journal of clinical immunology 2019; (39(1)):45-54 doi:10.1007/s10875-018-0577-9.
PMID: 30547383 - 12
Concomitant diagnosis of immune deficiency and Pseudomonas sepsis in a 19 month old with ecthyma gangrenosum by host whole-genome sequencing.
Sanford E, Farnaes L, Batalov S, et al.
Cold Spring Harbor molecular case studies 2018; (4(6)) doi:10.1101/mcs.a003244.
PMID: 30559311 - 13
X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world.
El-Sayed ZA, Abramova I, Aldave JC, et al.
The World Allergy Organization journal 2019; (12(3)):100018 doi:10.1016/j.waojou.2019.100018.
PMID: 30937141 - 14
Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency.
Weinberger T, Fuleihan R, Cunningham-Rundles C, Maglione PJ
Journal of clinical immunology 2019; (39(4)):440-447 doi:10.1007/s10875-019-00640-5.
PMID: 31089938 - 15
EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.
van Dongen JJM, van der Burg M, Kalina T, et al.
Frontiers in immunology 2019; (10()):1271 doi:10.3389/fimmu.2019.01271.
PMID: 31263462 - 16
Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases.
Wijetilleka S, Jayne D, Mukhtyar C, Karim MY
Lupus science & medicine 2019; (6(1)):e000337 doi:10.1136/lupus-2019-000337.
PMID: 31413852 - 17
A Novel BTK Gene Mutation in a Child With Atypical X-Linked Agammaglobulinemia and Recurrent Hemophagocytosis: A Case Report.
Han SP, Lin YF, Weng HY, et al.
Frontiers in immunology 2019; (10()):1953 doi:10.3389/fimmu.2019.01953.
PMID: 31481959 - 18
[Genetic diagnosis of patients with primary agammaglobulinemia treated at third level peruvian centers].
Matos-Benavides E, García-Gomero D, Inocente-Malpartida R, et al.
Revista peruana de medicina experimental y salud publica 2019; (36(4)):664-669 doi:10.17843/rpmesp.2019.364.4311.
PMID: 31967259 - 19
Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience.
Kwon WK, Choi S, Kim HJ, et al.
Allergy, asthma & immunology research 2020; (12(2)):292-305 doi:10.4168/aair.2020.12.2.292.
PMID: 32009323 - 20
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies.
Pecoraro A, Ricci S, Vultaggio A, et al.
Clinical drug investigation 2020; (40(3)):279-286 doi:10.1007/s40261-020-00885-8.
PMID: 32036588 - 21
Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia.
Fekrvand S, Yazdani R, Olbrich P, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(4)):405-417 doi:10.1111/pai.13228.
PMID: 32058651 - 22
Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling.
Rivière JG, Franco-Jarava C, Martínez-Gallo M, et al.
Frontiers in immunology 2020; (11()):46 doi:10.3389/fimmu.2020.00046.
PMID: 32117230 - 23
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality.
Lougaris V, Soresina A, Baronio M, et al.
The Journal of allergy and clinical immunology 2020; (146(2)):429-437 doi:10.1016/j.jaci.2020.03.001.
PMID: 32169379 - 24
Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach.
Wall LA, Wisner EL, Gipson KS, Sorensen RU
Frontiers in immunology 2020; (11()):522 doi:10.3389/fimmu.2020.00522.
PMID: 32296433 - 25
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
Soresina A, Moratto D, Chiarini M, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(5)):565-569 doi:10.1111/pai.13263.
PMID: 32319118 - 26
Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management.
Pashangzadeh S, Yazdani R, Nazari F, et al.
Endocrine, metabolic & immune disorders drug targets 2020; (20(9)):1434-1447 doi:10.2174/1871530320666200508114349.
PMID: 32384040 - 27
Evaluation of pulmonary findings in patients with humoral immunodeficiency.
Karalı Z, Karalı Y, Çekiç Ş, et al.
Turk pediatri arsivi 2020; (55(2)):174-183 doi:10.14744/TurkPediatriArs.2020.46656.
PMID: 32684763 - 28
Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.
Hanitsch L, Baumann U, Boztug K, et al.
European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.
PMID: 32845010 - 29
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency.
Saettini F, Poli C, Vengoechea J, et al.
Blood 2021; (137(4)):493-499 doi:10.1182/blood.2020006441.
PMID: 32905580 - 30
The Development of a New Questionnaire to Measure the Burden of Immunoglobulin Treatment in Patients with Primary Immunodeficiencies: The IgBoT-35.
Jones GL, Williams K, Edmondson-Jones M, et al.
Patient preference and adherence 2020; (14()):1567-1584 doi:10.2147/PPA.S234669.
PMID: 32982185 - 31
Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
Yeh YH, Hsieh MY, Lee WI, et al.
Frontiers in immunology 2020; (11()):2001 doi:10.3389/fimmu.2020.02001.
PMID: 33013854 - 32
Infection Phenotypes Among Patients with Primary Antibody Deficiency Mined from a US Patient Registry.
Pickett G, Motazedi T, Kutac C, et al.
Journal of clinical immunology 2021; (41(2)):374-381 doi:10.1007/s10875-020-00916-1.
PMID: 33205244 - 33
Ecthyma gangrenosum due to Pseudomonas aeruginosa sepsis as initial manifestation of X-linked agammaglobulinemia: a case report.
Huang H, Bai K, Fu Y, et al.
BMC pediatrics 2020; (20(1)):540 doi:10.1186/s12887-020-02436-8.
PMID: 33261572 - 34
X-Linked Agammaglobulinemia With Chronic Meningoencephalitis: A Diagnostic Challenge.
Saini AG, Radotra BD, Bhattarai D, et al.
Indian pediatrics 2021; (58(2)):169-173.
PMID: 33632949 - 35
X-linked agammaglobulinemia: ınvestigation of clinical and laboratory findings, novel gene mutations and prevention of ınfective complications in long-term follow-up.
Yıldırım İ, Topyıldız E, Bilgin RBG, et al.
American journal of clinical and experimental immunology 2021; (10(1)):37-43.
PMID: 33815962 - 36
Current Spectrum of Infections in Patients with X-Linked Agammaglobulinemia.
Paccoud O, Mahlaoui N, Moshous D, et al.
Journal of clinical immunology 2021; (41(6)):1266-1271 doi:10.1007/s10875-021-01043-1.
PMID: 33880703 - 37
Vaccination in PADs.
Milito C, Soccodato V, Collalti G, et al.
Vaccines 2021; (9(6)) doi:10.3390/vaccines9060626.
PMID: 34207916 - 38
Common Variable Immunodeficiency and Autoimmune Diseases: A Retrospective Study of 95 Adult Patients in a Single Tertiary Care Center.
Mormile I, Punziano A, Riolo CA, et al.
Frontiers in immunology 2021; (12()):652487 doi:10.3389/fimmu.2021.652487.
PMID: 34290696 - 39
An X-linked agammaglobulinemia (XLA) patient with fever and disturbance of consciousness: infection with Torque teno virus?
Liu H, Zhao J, Yang L, et al.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022; (115()):26-29 doi:10.1016/j.ijid.2021.11.041.
PMID: 34863924 - 40
Clinical, immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala, South India.
Madathil Govindaraj G, Jain A, Edavazhippurath A, et al.
Human immunology 2022; (83(4)):335-345 doi:10.1016/j.humimm.2022.01.003.
PMID: 35074268 - 41
Clinical and laboratory observation on immunoglobulin replacement therapy switching from an intravenous to a subcutaneous route in a Malaysian X-linked agammaglobulinemia patient.
Adli A, Wahab AA, Abdul Latiff AH, et al.
The Medical journal of Malaysia 2022; (77(1)):95-97.
PMID: 35087003 - 42
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.
van Leeuwen LPM, GeurtsvanKessel CH, Ellerbroek PM, et al.
The Journal of allergy and clinical immunology 2022; (149(6)):1949-1957 doi:10.1016/j.jaci.2022.04.002.
PMID: 35421449 - 43
Impact of Primary Immunodeficiency Diseases on the Life Experiences of Patients in Malaysia From the Caregivers' Perspective: A Qualitative Study.
Ahmed Meelad R, Abd Hamid IJ, Hashim IF, et al.
Frontiers in pediatrics 2022; (10()):846393 doi:10.3389/fped.2022.846393.
PMID: 35433547 - 44
Multiple Breath Washout for Early Assessment of Pulmonary Complications in Patients With Primary Antibody Deficiencies: An Observational Study in Pediatric Age.
Secchi T, Baselli LA, Russo MC, et al.
Frontiers in pediatrics 2022; (10()):773751 doi:10.3389/fped.2022.773751.
PMID: 35656375 - 45
Global Expansion of Jeffrey's Insights: Jeffrey Modell Foundation's Genetic Sequencing Program for Primary Immunodeficiency.
Quinn J, Modell V, Johnson B, et al.
Frontiers in immunology 2022; (13()):906540 doi:10.3389/fimmu.2022.906540.
PMID: 35757720 - 46
Response to mRNA COVID-19 vaccination in three XLA patients.
Squire JD, Joshi AY
Vaccine 2022; (40(36)):5299-5301 doi:10.1016/j.vaccine.2022.07.046.
PMID: 35934578 - 47
Meningoencephalitis in primary antibody deficiency: Our experience from northwest India.
Jindal AK, Chaudhary H, Tyagi R, et al.
Journal of neuroimmunology 2022; (371()):577952 doi:10.1016/j.jneuroim.2022.577952.
PMID: 36030644 - 48
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms.
Hanitsch LG
Current opinion in allergy and clinical immunology 2022; (22(6)):335-342 doi:10.1097/ACI.0000000000000856.
PMID: 36165423 - 49
Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report.
Wong YX, Shyur SD
Medicina (Kaunas, Lithuania) 2022; (58(10)) doi:10.3390/medicina58101457.
PMID: 36295618 - 50
A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.
Hernandez-Trujillo V, Zhou C, Scalchunes C, et al.
Journal of clinical immunology 2023; (43(6)):1468-1477 doi:10.1007/s10875-023-01502-x.
PMID: 37219739 - 51
Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.
Mizera D, Dziedzic R, Drynda A, et al.
Frontiers in immunology 2023; (14()):1275892 doi:10.3389/fimmu.2023.1275892.
PMID: 37901210 - 52
Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency.
Smits BM, Boland SL, Hol ME, et al.
The journal of allergy and clinical immunology. In practice 2024; (12(4)):1037-1048.e3 doi:10.1016/j.jaip.2023.12.047.
PMID: 38182096 - 53
Knowledge, awareness, and perception on genetic testing for primary immunodeficiency disease among parents in Malaysia: a qualitative study.
Ahmad Azahari AHS, Hakim Zada F, Ismail IH, et al.
Frontiers in immunology 2023; (14()):1308305 doi:10.3389/fimmu.2023.1308305.
PMID: 38283358 - 54
Psychosocial Evaluation of Adults with Primary Immunodeficiency.
Gumusburun R, Altay S, Cengiz H, et al.
Journal of clinical immunology 2024; (44(3)):71 doi:10.1007/s10875-024-01671-3.
PMID: 38411715 - 55
B-cells absence in patients diagnosed as inborn errors of immunity: a registry-based study.
Khoshnevisan R, Hassanzadeh S, Klein C, et al.
Immunogenetics 2024; (76(3)):189-202 doi:10.1007/s00251-024-01342-y.
PMID: 38683392 - 56
Fluoxetine Successfully Treats Intracranial Enterovirus E18 Infection in a Patient with CD79a Deficiency Arising from Segmental Uniparental Disomy of Chromosome 19.
Yu L, Zhang Y, Li W, et al.
Journal of clinical immunology 2024; (44(6)):137 doi:10.1007/s10875-024-01740-7.
PMID: 38805163 - 57
Impaired B-cell function in ERCC2 deficiency.
Rossmanith R, Sauerwein K, Geier CB, et al.
Frontiers in immunology 2024; (15()):1423141 doi:10.3389/fimmu.2024.1423141.
PMID: 39055713 - 58
Exclusive Characteristics of the p.E555K Dominant-Negative Variant in Autosomal Dominant E47 Deficiency.
Utsumi T, Tsumura M, Yashiro M, et al.
Journal of clinical immunology 2024; (44(7)):167 doi:10.1007/s10875-024-01758-x.
PMID: 39073655 - 59
Expanding the Clinical Phenotype with CD79A Mutation and Refractory Helicobacter Bilis Infection.
Sil A, Basu S, Arora K, et al.
Journal of clinical immunology 2024; (44(8)):187 doi:10.1007/s10875-024-01792-9.
PMID: 39215847 - 60
Immunoglobulin therapy for immunodeficiency.
Wilson BE, Freeman CM
Allergy and asthma proceedings 2024; (45(5)):364-370 doi:10.2500/aap.2024.45.240053.
PMID: 39294913 - 61
Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies.
Goede JS, Baumann CK, Cathomas R, et al.
Swiss medical weekly 2024; (154()):3559 doi:10.57187/s.3559.
PMID: 39462479 - 62
Outcomes of X-Linked Agammaglobulinaemia Patients.
Shillitoe B, Duque JSR, Lai SHY, et al.
Journal of clinical immunology 2024; (45(1)):40.
PMID: 39541002 - 63
Non-infectious pulmonary and gastrointestinal manifestations in primary antibody deficiencies: lessons for the clinic.
Franco M, Buso H, Carfora F, et al.
Expert review of clinical immunology 2025; (21(9)):1229-1249 doi:10.1080/1744666X.2025.2556435.
PMID: 40957411 - 64
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study.
Stenlander C, Lindahl H, Wahren-Borgström E, et al.
Journal of clinical immunology 2025; (45(1)):161.
PMID: 41240154 - 65
Clinical relevant Bruton's X-linked tyrosine kinase deficiency in a female with extreme X-chromosome inactivation.
NoorSaeed SM, Alrafiaah AS, Alghamdi M, et al.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2025; (22(1)):4 doi:10.1186/s13223-025-01002-0.
PMID: 41327272 - 66
A rare cause of cellulitis and bacteremia by Achromobacter xylosoxidans in a patient with X-linked agammaglobulinemia: a case report.
Wagle L, Aryal E, Bruges P, et al.
Annals of medicine and surgery (2012) 2025; (87(12)):8940-8943 doi:10.1097/MS9.0000000000004093.
PMID: 41377235 - 67
Pulmonary Manifestations of Inborn Errors of Immunity: Diagnostic and Therapeutic Insights.
Napiorkowska-Baran K, Cofta S, Treichel P, et al.
Life (Basel, Switzerland) 2025; (15(12)) doi:10.3390/life15121838.
PMID: 41465777 - 68
A rare case of TCF3-related agammaglobulinemia in a child with recurrent Haemophilus influenzae bacteremia.
Fang Y, Dubrocq G
Proceedings (Baylor University. Medical Center) 2026; (39(1)):152-154 doi:10.1080/08998280.2025.2552088.
PMID: 41487546 - 69
Vulnerability beyond infection: Effects of peer victimization on quality of life and psychosocial well-being in inborn errors of immunity.
Meric Z, Durcan G, Coban ZB, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2026; (37(3)):e70318 doi:10.1111/pai.70318.
PMID: 41800593 - 70
A case report of X-linked agammaglobulinemia complicated with necrotic pneumonia.
Zhang X, Zhu J
Translational pediatrics 2026; (15(4)):160 doi:10.21037/tp-2025-353.
PMID: 42158683 - 71
Adult Sibling Cases of Cutaneous Botryomycosis Leading to the Diagnosis of X-Linked Agammaglobulinemia.
Takeuchi M, Kaku Y, Hashikawa K, et al.
The American Journal of dermatopathology 2026; (48(8)):632-636 doi:10.1097/DAD.0000000000003306.
PMID: 42358014 - 72
Bronchiectasis in Inborn Errors of Immunity: Prevalence, Predictors, and Cardiopulmonary Complications in a Genetically Characterized Cohort.
Marangu-Boore D, Myint-Hpu K, Kang E, et al.
Journal of clinical immunology 2026; (46(1)).
PMID: 42414785 - 73
Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.
Lawrence MG, Kim VHD, Orange JS, Scherzer R
The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.
PMID: 42447994 - 74
Severe Polymicrobial Pneumonia With Septicemia After Interruption of Immunoglobulin Replacement in X-Linked Agammaglobulinemia: A Case Report.
Tran HD, Vo QH, Nguyen NP
Case reports in immunology 2026; (2026()):7974374 doi:10.1155/crii/7974374.
PMID: 42729739 - 75
Clinical and genetic characterization of X-linked agammaglobulinemia in a Colombian cohort.
Olaya Hernández M, Triviño Arias J, Arias Valderrama O, et al.
The World Allergy Organization journal 2026; (19(9)):101441 doi:10.1016/j.waojou.2026.101441.
PMID: 42733469 - 76
Frequency of depression and anxiety in patients with inborn errors of immunity: a cross-sectional study.
Wolff LJ, Witte T, Kahl KG, et al.
BMC psychiatry 2026; (26(1)).
PMID: 42745244